Most lately, it's been discovered that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds into a big range of endogenous opioids. In contrast to most opioid receptors, this receptor acts being a scavenger https://robertg062ihw1.nizarblog.com/profile